Vizsgálati helyszín
Acclaim Clinical Research
San Diego, California 92120, Egyesült ÁllamokMég nincs intézményhez kötve
- 15futó vizsgálat
- 12lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 27 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis18 vizsgálat
- 2. fázis7 vizsgálat
- 1/2. fázis2 vizsgálat
- Állapot
- Lezárult12 vizsgálat
- Fut, nem toboroz8 vizsgálat
- Toboroz6 vizsgálat
- Még nem toboroz1 vizsgálat
- Fő szponzor
- ModernaTX, Inc.6 vizsgálat
- Amgen3 vizsgálat
- Boehringer Ingelheim3 vizsgálat
- TriGemX Bio, Inc.3 vizsgálat
- Celldex Therapeutics2 vizsgálat
- és még 9
Futó vizsgálatok
Még nem toboroz
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
NCT07900633· 3. fázis· Eli Lilly and Company· Forrás
Contact: Mitch Biermann (principal investigator)
Toboroz
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
NCT07866066· 3. fázis· Amgen· Forrás
Toboroz
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07674654· 3. fázis· TriGemX Bio, Inc.· Forrás
Contact: Annemarie Vance
Toboroz
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07645924· 3. fázis· TriGemX Bio, Inc.· Forrás
Contact: Annemarie Vance
Fut, nem toboroz
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· 3. fázis· Amgen· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
A Study of Barzolvolimab in Patients With Atopic Dermatitis
NCT06727552· 2. fázis· Celldex Therapeutics· Forrás
Toboroz
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT06445023· 3. fázis· Celldex Therapeutics· Forrás
Fut, nem toboroz
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
NCT06334133· 3. fázis· vTv Therapeutics· Forrás
Fut, nem toboroz
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06290934· 2. fázis· Gilead Sciences· Forrás
Fut, nem toboroz
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
NCT05164094· 1/2. fázis· ModernaTX, Inc.· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
NCT06848075· 2. fázis· TriGemX Bio, Inc.· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
NCT06899217· 2. fázis· CinDome Pharma, Inc.· Forrás
Lezárult
Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
NCT06609460· 2. fázis· Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)· Forrás
Lezárult
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
NCT06299098· 2. fázis· Regeneron Pharmaceuticals· Forrás
Lezárult
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991· 3. fázis· BioNTech SE· Forrás
Lezárult
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
NCT06060457· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
NCT06033261· 1/2. fázis· ModernaTX, Inc.· Forrás
Lezárult
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
NCT05592418· 2. fázis· AIM ImmunoTech Inc.· Forrás
Lezárult
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
NCT05827978· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05724199· 3. fázis· Amgen· Forrás
Lezárult
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
NCT05566639· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
NCT05330975· 3. fázis· ModernaTX, Inc.· Forrás
Hibát jelzek